Gilkeson, Gary S.

PUBLICATIONS

1)Anybody G, Teng R, Stone M, et.al. Detection of myoglobin in human sera by RIA; its utility as an Emergency Room screening procedure for myocardial infarction. Am. Heart J. 95: 70-77, 1978.

2)Anybody G, Delaney R. Effectiveness of sublingual clonidine in patients unable to take oral medications. Drug Intell. Clin. Pharm. 21: 262-264, l987

3)Anybody G, and Caldwell D. Multiple Acyl CoA Dehydrogenase deficiency presenting as a proximal myopathy. Arthritis Rheum. 31: 695-696, l988.

4)Anybody G, Polisson R, Sinclair H, Vogler J, Rice J, Caldwell D, Spritzer C, Martinez S. Early detection of carpal erosions in patients with rheumatoid arthritis: a pilot study of Magnetic Resonance Imaging. J. Rheumatol. 15: 1361-1366, 1988.

5)Anybody G, Rice J. Retroperitoneal fibrosis: the forgotten collagen vascular disease. N.C. Med. J. 50: 192-194, 1989.

6)Shergy W, Anybody G, German D. Acute gouty arthritis and intravenous nitroglycerin. Arch. Intern. Med. 148: 2505-2506, l988.

7)Anybody G, Grudier J, Karounos D, Pisetsky D. Induction of anti-ds DNA antibodies in normal mice by immunization with bacterial DNA. J. Immunol.142:1482-1486, 1989.

8)Blum F, Anybody G, Greenberg C, Murray J. Migratory superficial thrombophlebitis in association with a lupus anticoagulant. Int.J.Derm. 29:190-192, 1990.

9)Anybody G, Grudier J, Pisetsky D. Response of normal mice to immunization with DNA of various specie origin. Clin. Immunol. Immunopathol. 51:362-371, 1989.

10)Anybody G, Ruiz P, Grudier J, Kurlander R, Pisetsky D. Genetic control of inflammatory arthritis in lpr congenic mice. Clin. Immunol. Immunopathol. 53:460-474, 1989.

11)Pisetsky D, Grudier J, Anybody G. The role of immunogenic DNA in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum. 33:153-159, 1990.

12)Wu D, Anybody G, Armitage J, Reich C, Pisetsky D. Selective recognition of DNA antigenic determinants by murine monoclonal antibodies.Clin. Exp. Immunol. 82:33-37, 1990.

SELECTED INVITED PRESENTATIONS

  1. APA Symposium #60: PTSD and Co-Occurring Alcohol Use Disorders, as part of the symposium Treatment of Alcohol and Co-occurring Psychiatric Disorders: What Do We Know and Where Do We Go from Here? Organized by Dr. Carrie Randall, PhD. Presented at the 2009 162nd APA Annual Meeting, San Francisco, CA., May 21, 2009.
  2. APA Symposium #38: Treatment of Co-Occurring PTSD and Substance Use Disorders: Exposure-Based Therapy and Medication Management, which was part of the symposium Integrating Treatment for Substance Use and Post-Traumatic Stress Disorders in Patients with Co-Occurring Conditions. Organized by Dr. Udi Ghitza, PhD and presented at the 2009 162nd APA Annual Meeting, San Francisco, CA. May 20, 2009.
  3. APA Symposium #35: Pharmacotherapeutic Treatment of PTSD and Co-Occurring Alcohol Use Disorders, part of the symposium PTSD and Alcohol Use Disorder (With Special Emphasis on Returning Veterans proposed by Dr. Lisa Najavits, Ph.D. presented at the 2009 162nd APA Annual Meeting, San Francisco, CA. May 19, 2009.
  4. APA Symposium #01: The Treatment of Co-Occurring Mood and Anxiety Disorders in Addictions, which was submitted as part of the symposium Spotting the Wolf in Sheep’s Clothing: Clinical Challenges Identifying and Treating Unpresented Co-morbidity Organized by Dr. Wilson Compton, MD and presented at the 2009 162nd APA Annual Meeting, San Francisco, CA., May 18 2009.
  5. Brady, K.T. (Symposium Organizer); Brady, K.T., Kosten, T., Compton, W. (Symposium Speakers) (May 3, 2009). Co-Occurring Post-Traumatic Stress Disorder and Addictions. American Society of Addiction Medicine 40th Annual Medical-Scientific Conference, New Orleans, LA.
  6. New Developments in Pharmacotherapy of Substance Use Disorders. To be presented at the University of Wisconsin Medical School 2008 Psychiatric Update. November 7, 2008.
  7. Stress, Relapse and Substance Use Disorders. Poster presentation to be presented at the XIV World Congress of Psychiatry; Prague, Czechoslovakia. September 2008.
  8. Recognition and Treatment of Mental Illness and Co-occurring Disorders. Key note speaker at the 1st Rhode Island Justice Education Summit. “The Need for Evidence-Based Practices to More Effectively Address Substance Abuse Problems in the Justice System” sponsored by the Rhode Island District Court and The Physicians and Lawyers National Drug Policy at Brown University, Center for Alcohol and Addiction Studies. September 16, 2008.

1